Insights Back to resource centre 22 November 2021 Using CANTAB to identify undiagnosed dementia cases using a web-based pre-screening tool in the MOPEAD project We recently caught up with Dr. Mercè Boada, the project coordinator of MOPEAD, and Medical Director of Ace Alzheimer Center Barcelona to discuss her recent publication supporting the use of CANTAB for the early detection of
Insights Back to resource centre 27 April 2018 7 tests for assessing cognition in early Alzheimer’s disease With rising life-expectancy, the number of cases of dementia and related disorders is increasing. In attempts to tackle the pandemic, treatment trials are moving earlier in the disease process. CANTAB offers a battery of tests specially targeted at assessing cognition in early Alzheimer’s
7 tests for assessing cognition in early Alzheimer’s disease Read More »
Insights Back to resource centre 12 April 2018 A solution for improving recruitment into early Alzheimer’s disease clinical trials Screening patients into early stage Alzheimer’s trials can be costly and time-consuming. Kenton Zavitz, PhD, Director of Clinical Affairs proposes a potential solution for improving recruitment into clinical trials. Key pointsScreening patients into early Alzheimer’s trials can be costly and time-consuming.Screening
A solution for improving recruitment into early Alzheimer’s disease clinical trials Read More »
Insights Back to resource centre 9 April 2018 The challenge of detecting early Alzheimer’s disease for clinical trials In this post, Director of Clinical Affairs, Dr Kenton Zavitz, looks at the challenge of recruiting the correct patients into Alzheimer’s disease trials. Key PointsAlzheimer’s disease (AD) is a global healthcare and economic crisis.Despite hundreds of clinical trials of new AD treatments,
The challenge of detecting early Alzheimer’s disease for clinical trials Read More »
